Don’t all drug companies go for approval anywhere they can? My experience with big pharma is that they sell their drugs globally - everywhere. Why not go for approval in these countries if Anavex feels, for some reason, that it will be difficult or longer in obtaining approval in the U.S. If you do the research you will find numerous antitrust cases involving instances where major pharma has blocked competition in the U.S. Just Google “pharmaceutical antitrust litigation blocking competition” or “pharmaceutical antitrust litigation blocking generic competition” or “pharmaceutical antitrust litigation blocking drug entry by filing baseless Citizen Petition with the FDA” or “blocking drug entry or approval by sham listing of patents in the FDA’s Orange Book, etc., etc. What’s more, I find it difficult to deny that the FDA is not or never has been influnenced by major pharma when so many from big pharma serve in positions with the FDA past, present, and future. I find it difficult to believe that in the real world companies do not try to defeat competition from other companies and that major pharma does not try to protect their drug pipelines when in fact they do. Bias exists everywhere. Agencies are sometimes biased. Judges are sometimes biased. We do not live in a perfet world. I am biased. This board is biased and everyone on it is biased to some extent one way or another. It may be that it is easier for a small biotech to get approval elsewhere than in the U.S. Also, once approved elsewhere, that company has a better chance of approval in the U.S. Major pharma sells their drugs everywhere at different prices in different coutries. That’s why folks travel to Mexico and Canada to buy drugs.
